No Data
No Data
VASO CORP | 10-Q: Quarterly report
Vaso Corporation Announces Financial Results for First Quarter 2024
For the three months ended March 31, 2024, revenue decreased by 1.6% to $18.7 million from $19.0 million for the same period of 2023, due primarily to decreases in the IT and equipment segments.
Vasomedical Reports Q4 Results
Should You Hold Vaso Corporation (VASO)?
Vaso Corporation, a Diversified Medical Technology Company Currently Trading on the OTCQX Market, to List on Nasdaq via SPAC Merger
Business Combination with Achari Ventures Holdings Corp. I is Expected to Be Completed in First Quarter of 2024Merger with Achari Ventures Holdings Corp. I (NASDAQ:AVHI) expected to improve capital ma
OTC Markets Group Welcomes Vaso Corporation to OTCQX
No Data